Literature DB >> 386594

5-Fuorouracil cardiotoxicity.

F Villani, A Guindani, A Pagnoni.   

Abstract

Two cases of 5-fluorouracil cardiotoxicity, resulting in one patient in myocardial infarction, are described. A review of the literature confirms that cardiotoxicity is a rare but genuine complication of 5-fluorouracil treatment; the cardiotoxic effect seems to range from mild angina without persistent electrocardiographic changes to severe myocardial infarction. No factors predictive of this complication were identified. The authors therefore feel it is advisable to stop 5-fluorouracil treatment when precordial pain occurs, even if the ECG (after angina) is normal, since angina can in some cases result in myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 386594     DOI: 10.1177/030089167906500410

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

1.  Fluorouracil and angina.

Authors:  C Sponzilli; W Toff
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-10

2.  The clinical syndrome of 5-fluorouracil cardiotoxicity.

Authors:  J F Ensley; B Patel; R Kloner; J A Kish; J Wynne; M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 3.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

4.  Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.

Authors:  C H Köhne; P Thuss-Patience; M Friedrich; P T Daniel; A Kretzschmar; T Benter; B Bauer; R Dietz; B Dörken
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

5.  Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.

Authors:  Christos Kosmas; Manolis S Kallistratos; Petros Kopterides; John Syrios; Helias Skopelitis; Nicolaos Mylonakis; Athanasios Karabelis; Nicolas Tsavaris
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-17       Impact factor: 4.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.